The Breast Friends Podcast Ep. 2 | The 2026 Breast Oncology Forecast
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
The Breast Friends Podcast Ep. 2 | The 2026 Breast Oncology Forecast
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
What’s coming in 2026 is about to reshape breast oncology.
In Episode 2, Dr. Jason Mouabbi and Dr. Paolo Tarantino go beyond published data to tackle the tough questions about what's next. They break down the evolving landscape of KEYNOTE-756, the rise of oral SERDs in the first line, and the role of HER2DX. From T-DXd in early disease and CNS risk in HER2+, to the promise of improving outcomes in triple-negative breast cancer, they are laying out the roadmap for the future of care.
The landscape is moving fast. Listen in as we prepare for the next wave of practice-changing data.
▶️ Watch on YouTube - https://youtu.be/Skt3jGMBncM
🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox, & Amazon Music
#BreastCancer #Oncology #OncologyPodcast #ClinicalTrials #CancerResearch #HER2Positive #TripleNegative #OralSERD #ADCs #MedicalOncology #MedEd #CancerCare